BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 16949255)

  • 1. Role of Langerhans cells in cutaneous protective immunity: is the reappraisal necessary?
    Asahina A; Tamaki K
    J Dermatol Sci; 2006 Oct; 44(1):1-9. PubMed ID: 16949255
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Cutaneous immune system].
    Schmitt D
    C R Seances Soc Biol Fil; 1994; 188(3):207-21. PubMed ID: 7834504
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multistep navigation of Langerhans/dendritic cells in and out of the skin.
    Jakob T; Ring J; Udey MC
    J Allergy Clin Immunol; 2001 Nov; 108(5):688-96. PubMed ID: 11692090
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early triggering of exclusive IFN-gamma responses of human Vgamma9Vdelta2 T cells by TLR-activated myeloid and plasmacytoid dendritic cells.
    Devilder MC; Allain S; Dousset C; Bonneville M; Scotet E
    J Immunol; 2009 Sep; 183(6):3625-33. PubMed ID: 19710464
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Innate immunity mediated by epidermal keratinocytes promotes acquired immunity involving Langerhans cells and T cells in the skin.
    Sugita K; Kabashima K; Atarashi K; Shimauchi T; Kobayashi M; Tokura Y
    Clin Exp Immunol; 2007 Jan; 147(1):176-83. PubMed ID: 17177977
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dendritic cells from bench to bedside and back.
    Adema GJ
    Immunol Lett; 2009 Feb; 122(2):128-30. PubMed ID: 19121337
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interferon-gamma: biologic functions and HCV therapy (type I/II) (1 of 2 parts).
    Gattoni A; Parlato A; Vangieri B; Bresciani M; Derna R
    Clin Ter; 2006; 157(4):377-86. PubMed ID: 17051976
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TLR2-activated human langerhans cells promote Th17 polarization via IL-1beta, TGF-beta and IL-23.
    Aliahmadi E; Gramlich R; Grützkau A; Hitzler M; Krüger M; Baumgrass R; Schreiner M; Wittig B; Wanner R; Peiser M
    Eur J Immunol; 2009 May; 39(5):1221-30. PubMed ID: 19350551
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced contact hypersensitivity and antiviral immune responses in vivo by keratinocyte-targeted overexpression of IL-15.
    Loser K; Mehling A; Apelt J; Ständer S; Andres PG; Reinecker HC; Eing BR; Skryabin BV; Varga G; Schwarz T; Beissert S
    Eur J Immunol; 2004 Jul; 34(7):2022-31. PubMed ID: 15214050
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insights into Langerhans cell function from Langerhans cell ablation models.
    Kaplan DH; Kissenpfennig A; Clausen BE
    Eur J Immunol; 2008 Sep; 38(9):2369-76. PubMed ID: 18792030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined Toll-like receptor agonists synergistically increase production of inflammatory cytokines in human neonatal dendritic cells.
    Krumbiegel D; Zepp F; Meyer CU
    Hum Immunol; 2007 Oct; 68(10):813-22. PubMed ID: 17961769
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The role of Langerhans cells in the skin immune system].
    Chomiczewska D; Trznadel-Budźko E; Kaczorowska A; Rotsztejn H
    Pol Merkur Lekarski; 2009 Mar; 26(153):173-7. PubMed ID: 19388527
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Skin inflammation is not sufficient to break tolerance induced against a novel antigen.
    Holcmann M; Stoitzner P; Drobits B; Luehrs P; Stingl G; Romani N; Maurer D; Sibilia M
    J Immunol; 2009 Jul; 183(2):1133-43. PubMed ID: 19570825
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Type 1 cytokine/chemokine production by mouse NK cells following activation of their TLR/MyD88-mediated pathways.
    Sawaki J; Tsutsui H; Hayashi N; Yasuda K; Akira S; Tanizawa T; Nakanishi K
    Int Immunol; 2007 Mar; 19(3):311-20. PubMed ID: 17289654
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcriptional profiling of human skin-resident Langerhans cells and CD1a+ dermal dendritic cells: differential activation states suggest distinct functions.
    Santegoets SJ; Gibbs S; Kroeze K; van de Ven R; Scheper RJ; Borrebaeck CA; de Gruijl TD; Lindstedt M
    J Leukoc Biol; 2008 Jul; 84(1):143-51. PubMed ID: 18436579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Langerhans cells are susceptible to measles virus infection and actively suppress T cell proliferation.
    Steineur MP; Grosjean I; Bella C; Kaiserlian D
    Eur J Dermatol; 1998 Sep; 8(6):413-20. PubMed ID: 9729058
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Freshly isolated Langerhans cells negatively regulate naïve T cell activation in response to peptide antigen through cell-to-cell contact.
    Imai Y; Hayashi N; Yasuda K; Tsutsui H; Mizutani H; Nakanishi K
    J Dermatol Sci; 2008 Jul; 51(1):19-29. PubMed ID: 18367382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dyslipidemia inhibits Toll-like receptor-induced activation of CD8alpha-negative dendritic cells and protective Th1 type immunity.
    Shamshiev AT; Ampenberger F; Ernst B; Rohrer L; Marsland BJ; Kopf M
    J Exp Med; 2007 Feb; 204(2):441-52. PubMed ID: 17296788
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor microenvironment is multifaceted.
    Sautès-Fridman C; Cherfils-Vicini J; Damotte D; Fisson S; Fridman WH; Cremer I; Dieu-Nosjean MC
    Cancer Metastasis Rev; 2011 Mar; 30(1):13-25. PubMed ID: 21271351
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nadifloxacin downmodulates antigen-presenting functions of epidermal Langerhans cells and keratinocytes.
    Murata K; Sugita K; Kobayashi M; Kabashima K; Tokura Y
    J Dermatol Sci; 2006 May; 42(2):91-9. PubMed ID: 16431082
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.